Treatment-resistant depression in late life

Journal of Geriatric Psychiatry and Neurology

Volumn 11, Issue 4, 1998, Pages 186-193

  Mulsant, Benoit H ^a   Pollock, Bruce G ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; FLUVOXAMINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; COGNITION; COMORBIDITY; CONSTIPATION; DEPRESSION; DIAGNOSTIC ACCURACY; DIARRHEA; DRUG CHOICE; DYSURIA; ELECTROCONVULSIVE THERAPY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SUICIDE; TINNITUS; TREATMENT FAILURE; TREATMENT INDICATION; TREMOR; VERTIGO; XEROSTOMIA;

EID: 0032409189     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198879901100404     Document Type: Review

References (71)

1. Buschmann MT, Dixon MA, Tichy AM. Geriatric depression. Home Healthcare Nurse 1995; 13:47-56.
2. Baldwin RC. Refractory depression in late life: a review of treatment options. Rev Clin Gerontol 1996; 6:343-348.
3. Zubenko GS, Mulsant BH, Sweet RA, Pasternak RE, Tu XM. Mortality of elderly patients with psychiatric disorders. Am J Psychiatry 1997; 154:1360-1368.
4. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996; 19:179-200.
5. Baldwin RC, Simpson S. Prognosis and outcome studies in late life depression. Clin Neurosci 1997; 4:16-22.
6. Diagnosis and Treatment of Depression in Late Life. The NIH Consensus Development Conference Statement. Psychopharmacol Bull 1993; 29:87-100.
7. Kamholz BA, Mellow AM. Management of treatment resistance in the depressed geriatric patient. Psychiatr Clin North Am 1996; 19:269-286.
8. Guscott R, Grof P. The clinical meaning of refractory depression: a review for the clinician. Am J Psychiatry 1991; 148:695-704.
9. Mulsant BH, Singhai S, Kunik M. New developments in the treatment of late life depression. In: Hales RE, Yudovsky SC, eds. Practical clinical strategies in treating depression and anxiety disorders in a managed care environment. Washington, DC: American Psychiatric Association, 1996:55-61.
10. Wragg RD, Jeste DV. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 1989; 146:577-589.
11. Mulsant BH, Pollock BG, Nebes RD, Hoch CC, Reynolds CF. Depression in Alzheimer's dementia. In: Heston LL, ed. Progress in Alzheimer's disease and similar conditions. Washington, DC: American Psychiatric Press, 1997:161-175.
12. Rothschild AJ. The diagnosis and treatment of late life depression. J Clin Psychiatry 1996; 57 (suppl 5):5-ll.
13. Lyness JM, Bruce ML, Koenig HG, Depression and medical illness in late life: report of a symposium. J Am Geriatr Soc 1996; 44:198-203.
14. t 14. Mischoulon D. The role of folate in major depression: mecha nisms and clinical implications. Am Soc Clin Psychopharmacol Prog Notes 1996; 7:4-5.
15. Alpert JE, Fava M. Nutrition and depression: the role of folate. NutrRev 1997; 55:145-149.
16. Huto BR. Folate and cobalamin in psychiatric illness. Comp Psychiatry 1997; 38:305-314.
17. Martinez RA, Mulsant BH, Meyers BS, Lebowitz B. Delusional depression in late life: a research agenda. Am J Geriatr Psychiatry 1996; 4:77-84.
18. Mulsant BH, Stergiou A, Keshavan MS, Schizophrenia in late life: elderly patients admitted to an acute care psychiatric hospital. Schizophr Bull 1993; 19:709-721.
19. Chan CH, Janicak PG, Davis JM, Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 1987; 48:197-200.
20. Kroessler D. Relative efficacy rates for therapies of delusional depression. Convuls Ther 1985; 1:173-182.
21. Gatti F, Bellini L, Gasperini M, Fluvoxamine alone in the treatment of delusional depression. Am J Psychiatry 1996; 153:414-416.
22. Zanardil R, Franchini L, Gasperini M, Ferez J, Smeraldi E. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 1996; 153:1631-1633.
23. Shelton RC. Treatment-resistant depression: therapeutic approaches. Medscape Mental Health 1996; 1(2).
24. GoffDC, Jenike MA. Treatment-resistant depression in the elderly. J Am Gerlatr Soc 1986; 34:63-70.
25. Bonner D, Howard R. Treatment-resistant depression in the elderly. Int Psychogeriatr 1995; 7(suppl):83-94.
26. Koenig HG, Cohen H J, Blazer DG, Krishnar KRR, Sibert TE. Profile of depressive symptoms in younger and older medical inpatients with major depression. J Am Geriatr Soc 1993; 41:1169-1176.
27. Reimherr FW, Chouinard G; Cohn CK, Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 1990; 51(12, suppl B):18-27.
28. Miller MD, Pollock BG, Rifai AH, Longitudinal analysis of nortriptyline side effects in elderly depressed patients. J Geriatr Psychiatr Neurol 1991; 4:226-230.
29. Rollman BL, Block MR, Schulberg HC. Symptoms of major depression and tricyclic side effects in primary care patients. J Gen Intern Med 1997; 12:284-291.
30. Amsterdam JD, Hornig-Rohan M. Treatment algorithms in treatment-resistant depression. Psychiatr Clin North Am 1996; 19:371-386.
31. Heston LL, Garrad J, Makris L, Inadequate treatment of depressed nursing home elderly. J Am Geriatr Soc 1992; 40:1117-1122.
32. Johnson DAW. Depression: treatment compliance in general practice. Acta Psychiatr Scand Suppl 1981; 290:447-453.
33. Agency for Health Care Policy and Research (AHCPR) Depression Guideline Panel, US Department of Health and Human Services. Clinical practice guideline, depression in primary care: Volume 1. Detection and diagnosis. (AHCPR publication no. 93-0550). Washington, DC: US Government Printing office, 1993.
34. Dew MA, Reynolds CF, Houck PR, Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry 1997; 54:1016-1024.
35. Georgotas A, McCue RC. The additional benefit of extending an antidepressant trial past seven weeks in the depressed elderly. Int J Geriatr Psychiatry 1989; 4:191-195.
36. Greenhouse JB, Kupfer DJ, Frank E, Jarrett DB, Rejman KA. Analysis of time to stabilization in the treatment of depression: biological and clinical correlates. J Affect Disord 1987; 13:259-266.
37. Thase ME, Fava M, Halbreich U, A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 1996; 53:777-784.
38. Mulsant BH, Reynolds CF, Shear K, Comorbid anxiety disorders in late life depression. Anxiety 1996; 2:242-247.
39. Cohn CK, Shrivastava R, Mendels J, Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990; 51(12, suppl B):28-33.
40. Rosenberg C, Damsbo N, Fuglum E, Jacobsen LV, Horsgard S. Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study. Int Clin Psychopharmacol 1994; 9(suppl 1):41-48.
41. Overo KF. Citalopram vs amitriptyline in the treatment of depressed elderly in a general practice setting (poster). Presented at the annual meeting of the American Psychiatric Association, San Diego, 1997.
42. Katzelnick DJ, Kobak KA, Jefferson JW, Prescribing pattern of antidepressant medications for depression in a health care organization. Psychopharmacol Bull 1995; 31:583.
43. Orrell M, Collins E, Shergill S, Katona C. Management of depression in the elderly by general practitioners. I. Use of antidepressants. Fam Pract 1995; 12:5-11.
44. Pollock BG. Issues in psychotropic drug development for the elderly. In: Bergener M, Brocklehurst JC, Finkel SI, eds. Aging, health, and healing. New York: Springer, 1995:235-242.
45. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319:1701-1707.
46. Mulsant BH, Pollock BG, Rosen J. Newer antidepressants and antipsychotics in geriatric psychiatry. Ann Long-Term Care 1997; 5:240-248.
47. Montgomery SA, Henry J, McDonald G, Selective serotonin reuptake inhibitors: metaanalysis of discontinuation rates. Int Clin Psychopharmacol 1994; 9:47-53.
48. Reynolds CF, Alexopoulos G, Katz I, Treatment of geriatric mood disorders. Curr Rev Mood Disord 1997; 1:189-202.
49. Roose SP, Glassman AH, Attia E, Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151:1735-1739.
50. Mulsant BH, Pollock BG, Nebes RD, A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: six-week outcome. J Clin Psychiatry. In press.
51. Friedhoff AJ, Alpert M, Clary C, Sertraline versus nortriptyline in the depressed elderly. In: Program and Abstracts on New Research. 151st Annual Meeting of the American Psychiatric Association. Toronto: APA, 1998.
52. Tollefson GD, Bosomworth JC, Heiligenstein JH, A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. Int Psychogeriatr 1995; 7:89-104.
53. Newhouse PA, Richter E. A double-blind comparison ofsertraline and fluoxetine in elderly depressed outpatients. Presented at the annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 1994.
54. Kasper S, Heiden A. Do SSRIs differ in their antidepressant efficacy? Hum Psychopharmacol 1995; 10:8163-8172.
55. Nemeroff CB. Augmentation strategies in patients with refractory depression. Depress Anxiety 1996/1997; 4:169-181.
56. Thase ME, Blomgren SL, Birkett MA, Aptcr JT, Tepner RG. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline. J Clin Psychiatry 1997; 58:16-21.
57. Brown WA, Harrison W. Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry 1995; 56:30-34.
58. Georgotas A, Friedman E, McCarthy J, Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors. Biol Psychiatry 1983; 18:195-205.
59. Rowland RH, Thase ME. Switching strategies for the treatment of unipolar major depression. Mod Probl Pharmacopsychiatry 1997; 25:56-65.
60. Schweitzer I, Tuckwell V, Johnson G. A review of the use of augmentation therapy for the treatment of resistant depression: implications for the clinician. Aust N Z J Psychiatry 1997; 31:340-352.
61. Zimmer B, Rosen J, Thornton JE, Percel JM, Reynolds CF. Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients. J Clin Psychopharmacol 1991; 11:254-256.
62. Flint AJ, Rifat SL. The effect of sequential antidepressant treatment on geriatric depression. J Affect Disord 1996; 36:95-105.
63. Sproule BA, Naranjo CA, Brenmer KE, Hassan PC. Selective serotonin reuptake inhibitors and CNS drug interactions. Clin Pharmacokinet 1997; 33:454-471.
64. Gram LF, Hansen MGJ, Sindrup STH, Citalopram: interaction studies with levomepromazine, imipramine, and lithium. Ther Drug Monit 1993; 15:18-24.
65. Preskorn SH. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative metabolism. Clin Pharmacokinet 1997; 32(suppl 1):1-21.
66. Solai LK, Mulsant BH, Pollock BG, Effect of sertraline on plasma nortriptyline levels in depressed elderly. JClin Psychiatry 1997; 58:440-443.
67. Reynolds CF, Frank E, Perel JM, High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression. Am J Psychiatry 1996; 153:1418-1422.
68. American Psychiatric Association Task Force on ECT. The practice of electroconvulsive therapy: recommendations for treatment, training and privileging. Washington, DC: American Psychiatric Association Press, 1990.
69. Prudic J, Haskett RF, Mulsant B, Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996; 153:985-992.
70. Sackeim HA, Prudic J, Devanand DP, The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990; 10:96-104.
71. Fox HA, Salzman C. Resistant depression in the very old - a role for maintenance ECT? Harv Rev Psychiatry 1995; 3:152-155.